Dostarlimab plus chemotherapy appears to yield favorable overall survival in patients with mismatch repair proficient endometrial cancer.
Mansoor Raza Mirza, MD
Advertisement
Articles by Mansoor Raza Mirza, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears Phase 3 Lacutamab Protocol in Cutaneous T-Cell Lymphomas
2
Finding a “Sweet Spot” for Smoldering Multiple Myeloma Management
3
How Supportive Care Methods Can Improve Oncology Outcomes
4
AQUILA Shows “Striking” Benefits With Daratumumab in Smoldering Myeloma
5
